Brief: Acelrx Pharmaceuticals Reports Second Quarter 2022 Financial Results And Provides Corporate Update
11/08/2022 21:49
Aug 11 (Reuters) - AcelRx Pharmaceuticals Inc ACRX.O :
* ACELRX PHARMACEUTICALS REPORTS SECOND QUARTER 2022
FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
* Q2 EARNINGS PER SHARE $0.48
* IN JUNE, REALIGNED COST STRUCTURE TO REDUCE HEADCOUNT BY
ABOUT
40%, GENERATING EXPECTED ANNUAL SAVINGS OF $9 MILLION
Source text for Eikon: ID:nPn674JzKa
Further company coverage: ACRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Talphera
See all newsTalphera Inc reports results for the quarter ended June 30 - Earnings Summary
Talphera Inc expected to post a loss of 7 cents a share - Earnings Preview
Talphera Q1 net loss narrows as costs rise on higher development spending
Talphera Q4 net loss widens as operating expenses rise
Brief: Talphera Announces 50% Enrollment Milestone In Ongoing Nephro-Crrt Registrational Trial